Recent Updates
Recently added Catalysts
Biotech Stock Screener
| Ticker | Name | Price | 30-Day Trend | Pipeline | Segment | Valuation | Therapeutic Area | Market Capital | Volume | P/E RATIO | Insiders | EPS | D/E RATIO | Live-Cash | Burn Rate | Ebitda | Runway | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 A | Agilent Technologies, Inc. | 134.29 0.52 % | -0.8% | N/A (Dx) | Diagnostics | Diagnostics | 38.14 B | 2.18 M | 27.12 | -479.97 K | 5.00 | 0.49 | 1.81 B | 116.33 M | 1.84 B | 15.11 | PROFITABLE | |
 AAPG | Ascentage Pharma Group International - American Depository Shares | 19.97 5.66 % | +0.5% | C 53 | Pharma Commercial | Overvalued | 1.97 B | 3.63 K | 0.00 | - | -1.94 | 1.50 | 171.93 M | 14.56 M | -156.72 M | 24.28 | — | |
 AARD | Aardvark Therapeutics, Inc. | 7.6 52.00 % | +81.0% | C 50 | Pharma Commercial | Fair Value | 99.05 M | 4.09 M | 0.00 | - | -3.21 | 0.00 | 91.20 M | 6.29 M | -74.68 M | 12.30 | STABLE | |
 ABBV | AbbVie Inc. | 248.08 -0.73 % | +13.5% | A 91 | Pharma Commercial | Fair Value | Cardiovascular Disease, Dermat Read More | 380.57 B | 5.78 M | 106.24 | -2.83 M | 2.03 | 0.00 | 9.39 B | 1.77 B | 29.19 B | 5.31 | PROFITABLE |
 ABCL | AbCellera Biologics Inc. | 6.8 -6.72 % | +18.7% | D 31 | Biotech Commercial | Richly Valued | 1.87 B | 7.28 M | -12.78 | 95.40 K | -0.48 | 0.15 | 504.73 M | 11.17 M | -181.09 M | 43.20 | HEALTHY | |
 ABEO | Abeona Therapeutics Inc. | 6.98 -1.97 % | +20.8% | C 47 | Pharma Commercial | Fair Value | 324.30 M | 1.63 M | 6.07 | -4.31 M | 1.30 | 0.16 | 168.27 M | 6.60 M | -89.14 M | 23.50 | STABLE | |
 ABOS | Acumen Pharmaceuticals, Inc. | 2.63 -2.59 % | +3.5% | C 41 | Biotech Clinical | Richly Valued | 171.18 M | 319.07 K | -1.28 | -199.89 K | -1.86 | 0.36 | 128.40 M | 8.04 M | -114.43 M | 14.00 | STABLE | |
 ABSI | Absci Corporation | 10.6 -7.59 % | +74.3% | D 28 | Biotech Clinical | Richly Valued | 795.12 M | 4.70 M | 0.00 | -161.13 K | -0.83 | 0.03 | 125.70 M | 8.77 M | -117.14 M | 12.10 | STABLE | |
 ABT | Abbott Laboratories | 93.93 -0.50 % | +8.8% | A 85 | MedTech Commercial | MedTech | Analgesia/Anesthesiology/Anti- Read More | 151.49 B | 6.91 M | 24.23 | -2.68 M | 3.61 | 0.65 | 7.29 B | 788.67 M | 11.19 B | 9.25 | PROFITABLE |
 ABUS | Arbutus Biopharma Corporation | 4.8 -6.61 % | +4.3% | D 36 | Pharma Commercial | Overvalued | 841.51 M | 2.95 M | 5.18 | - | 0.83 | 0.02 | 95.23 M | 2.70 M | 155.14 M | 33.20 | HEALTHY | |
 ABVC | ABVC BioPharma, Inc. | 1.51 4.14 % | +7.1% | D 30 | Pharma Clinical | Overvalued | 32.50 M | 179.38 K | -3.21 | - | -0.39 | 0.25 | 202.51 K | 298.00 K | -7.55 M | 0.73 | CRITICAL | |
 ABVX | Abivax SA | 139.9 -0.60 % | +8.0% | C 49 | Pharma Commercial | Richly Valued | 9.79 B | 837.74 K | 0.00 | - | -5.25 | 0.08 | 606.82 M | 17.17 M | -300.56 M | 32.98 | — | |
 ACAD | ACADIA Pharmaceuticals Inc. | 26.22 -0.72 % | +21.2% | C 58 | Pharma Commercial | Fair Value | 3.58 B | 1.44 M | 9.51 | -929.12 K | 2.22 | 0.04 | 851.46 M | 10.29 M | 92.71 M | 82.74 | PROFITABLE | |
A ACB | Aurora Cannabis Inc. Common Shares | 2.71 0.37 % | -26.2% | F 10 | Tools & Services Pre-Clinical | Tools & Services | 194.51 M | 941.00 K | -2.99 | - | -1.15 | NaN | - | - | - | NaN | — | |
 ACET | Adicet Bio, Inc. | 8.83 -1.23 % | +2.2% | D 30 | Pharma Clinical | Richly Valued | 75.81 M | 60.80 K | -0.54 | - | -15.03 | 0.10 | 137.59 M | 7.16 M | -107.78 M | 17.20 | STABLE | |
 ACH | Accendra Health, Inc. | 3.42 3.64 % | +18.3% | — | — | — | 216.73 M | 262.20 K | 0.00 | -91.44 K | -14.06 | 0.00 | 336.88 M | 16.69 M | 344.06 M | 18.20 | STABLE | |
A ACHC | Acadia Healthcare Company, Inc. | 31.28 -0.38 % | +31.6% | — | — | — | 2.39 B | 2.97 M | -2.13 | -176.14 K | -12.19 | NaN | 158.47 M | - | - | NaN | PROFITABLE | |
 ACHV | Achieve Life Sciences, Inc. | 6.11 -4.53 % | +15.3% | B 61 | Biotech Commercial | Undervalued | 516.38 M | 2.05 M | -4.51 | - | -1.12 | 1.40 | 29.27 M | 2.31 M | -52.23 M | 10.70 | CAUTION | |
 ACIU | AC Immune SA | 2.39 -8.08 % | -13.1% | D 36 | Pharma Clinical | Overvalued | 246.29 M | 199.78 K | -2.95 | -143.77 K | -0.82 | 0.14 | 33.82 M | - | - | 0.00 | — | |
A ACOG | Alpha Cognition Inc. | 8.41 -1.29 % | +41.6% | Pharma | — | 131.30 M | 56.69 K | -5.12 | 3.66 M | -1.18 | -2.72 | 54.25 M | 3.93 M | -11.45 M | 11.90 | CAUTION | ||
A ACON | Aclarion, Inc. Common Stock | 2.844 -2.27 % | -9.7% | F 13 | Tools & Services Clinical | Tools & Services | 7.37 M | 20.02 K | -0.19 | 50.92 K | -17.21 | NaN | 19.00 M | 881.00 K | - | 19.80 | STABLE | |
 ACRS | Aclaris Therapeutics, Inc. | 5.58 -2.28 % | +22.1% | C 54 | Pharma Commercial | Fair Value | 646.64 M | 1.40 M | -8.26 | -1.40 M | -0.56 | 0.01 | 105.42 M | 6.05 M | -77.86 M | 15.20 | STABLE | |
 ACRV | Acrivon Therapeutics, Inc. | 1.96 -4.39 % | +20.2% | C 44 | Pharma Clinical | Fair Value | 67.20 M | 349.41 K | -0.78 | -7.03 M | -2.00 | 0.03 | 97.74 M | 6.85 M | -81.01 M | 12.30 | STABLE | |
 ACTU | Actuate Therapeutics, Inc. | 1.21 -1.63 % | -41.8% | D 26 | Pharma Clinical | Richly Valued | 56.94 M | 255.72 K | 0.00 | - | -0.99 | 0.11 | 8.13 M | 1.67 M | -21.83 M | 3.00 | DISTRESSED | |
 ACXP | Acurx Pharmaceuticals, Inc. | 1.5 2.74 % | -24.6% | D 27 | Pharma Clinical | Richly Valued | Gastroenterology, Infectious D Read More | 7.74 M | 89.73 K | -0.41 | - | -4.40 | 0.00 | 9.25 M | 469.00 K | -7.63 M | 17.70 | STABLE |
 ADAG | Adagene Inc. | 3.94 2.34 % | +0.0% | C 53 | Pharma Clinical | Fair Value | 160.64 M | 376.84 K | -9.06 | - | -0.37 | 0.12 | 74.52 M | 1.31 M | -20.91 M | 56.95 | — | |
 ADCT | ADC Therapeutics SA | 1.29 -0.77 % | -62.6% | C 51 | Pharma Commercial | Undervalued | 403.20 M | 1.33 M | -3.01 | - | -1.05 | 0.00 | 231.01 M | 9.90 M | -104.12 M | 21.00 | STABLE | |
 ADGM | Adagio Medical Holdings, Inc | 0.57 0.69 % | -21.4% | F 2 | MedTech Clinical | MedTech | 18.68 M | 200.83 K | 0.00 | - | -1.39 | 4.21 | 12.91 M | 1.38 M | -18.39 M | 7.40 | CAUTION | |
 ADIL | Adial Pharmaceuticals, Inc | 2.78 -0.71 % | +9.9% | D 21 | Pharma Clinical | — | Analgesia/Anesthesiology/Anti- Read More | 5.06 M | 51.05 K | -0.24 | 130.00 K | -9.90 | 0.00 | 4.58 M | 537.00 K | -7.53 M | 6.40 | CAUTION |
 ADMA | ADMA Biologics Inc | 9.08 -2.05 % | +14.5% | D 36 | Biotech Commercial | Richly Valued | Infectious Disease (viral), In Read More | 1.76 B | 2.34 M | 11.21 | 250.87 K | 0.69 | 0.52 | 138.15 M | 10.69 M | 214.82 M | 12.92 | PROFITABLE |
 ADPT | Adaptive Biotechnologies Corporation | 21.06 -3.39 % | +38.6% | C 42 | Biotech Commercial | Overvalued | 2.42 B | 1.91 M | -46.83 | -61.00 M | -0.32 | 0.96 | 218.33 M | 3.18 M | -28.80 M | 66.50 | HEALTHY | |
A ADUS | Addus HomeCare Corp. | 108.21 -1.38 % | +15.7% | — | — | — | 1.72 B | 220.35 K | 17.69 | -90.17 K | 5.28 | NaN | 103.06 M | - | - | NaN | PROFITABLE | |
 ADVB | Advanced Biomed Inc. | 5.16 -3.10 % | +32.0% | N/A (Dx) | Diagnostics | Diagnostics | 5.46 M | 15.35 K | 24.81 | - | 0.16 | 0.08 | 2.60 M | 163.00 K | -81.53 K | 14.10 | STABLE | |
 ADXN | Addex Therapeutics Ltd | 6.34 0.00 % | -4.7% | D 33 | Pharma Clinical | Overvalued | Analgesia/Anesthesiology/Anti- Read More | 6.89 M | 323.00 | -0.70 | - | -9.10 | 0.01 | 2.07 M | 219.23 K | -3.40 M | 9.43 | — |
 AEMD | Aethlon Medical, Inc. | 0.708 1.87 % | -75.9% | F 10 | MedTech Pre-Clinical | MedTech | 3.47 M | 65.41 K | -0.05 | -204.30 K | -45.83 | 0.06 | 5.03 M | 583.00 K | -6.82 M | 7.50 | CAUTION | |
 AEON | AEON Biopharma, Inc. | 0.4831 -3.90 % | -32.6% | D 24 | Pharma Clinical | Richly Valued | 20.45 M | 66.19 K | 0.00 | - | -4.35 | 0.00 | 6.24 M | 879.00 K | -18.81 M | 5.20 | DISTRESSED | |
 AGEN | Agenus Inc. | 3.35 3.40 % | -1.5% | C 52 | Biotech Commercial | Fair Value | 140.75 M | 833.40 K | 2.02 | -111.94 K | 1.74 | 0.00 | 35.00 M | 11.98 M | 15.19 M | 0.90 | CRITICAL | |
 AGIO | Agios Pharmaceuticals, Inc. | 41.23 -3.65 % | +35.5% | C 53 | Pharma Commercial | Overvalued | Endocrinology/Metabolism/Bone, Read More | 1.58 B | 1.13 M | -3.66 | -301.01 K | -7.25 | 0.03 | 737.04 M | 39.64 M | -470.27 M | 16.20 | STABLE |
A AGL | agilon health, inc. | 114.85 -0.71 % | +27.1% | — | — | — | 315.85 M | 206.29 K | -0.78 | -297.89 K | -24.46 | NaN | 231.41 M | - | - | NaN | PROFITABLE | |
 AGMB | AgomAb Therapeutics NV | 13.08 0.38 % | +13.3% | D 33 | Biotech Clinical | Overvalued | 560.47 M | 47.24 K | 0.00 | - | 0.00 | 0.01 | 101.49 M | - | - | 0.00 | — | |
 AGPU | Axe Compute Inc. | 7.36 5.60 % | +10.8% | N/A (Device) | MedTech | MedTech | 55.56 M | 107.95 K | 0.00 | -99.15 K | -147.99 | 0.04 | 6.93 M | 1.25 M | -28.87 M | 3.60 | DISTRESSED | |
A AHCO | AdaptHealth Corp. Common Stock | 10.22 0.59 % | -1.3% | — | — | — | 1.65 B | 1.12 M | -23.09 | -408.88 K | -0.53 | NaN | 47.96 M | - | - | NaN | PROFITABLE | |
A AHG | Akso Health Group ADS | 1.52 2.01 % | -1.3% | — | — | — | 1.96 B | 24.54 K | -4.85 | - | -0.47 | NaN | - | - | - | NaN | — | |
A AIDX | 20/20 Biolabs, Inc. Common Stock | 0.58912 1.05 % | -38.0% | — | — | — | 19.63 M | 86.50 K | 0.00 | - | 0.00 | NaN | 4.22 M | 430.00 K | - | 8.10 | CAUTION | |
 AIFF | Firefly Neuroscience, Inc. | 1.15 -7.26 % | -36.1% | — | — | — | 27.25 M | 145.21 K | 0.00 | - | -0.66 | 0.00 | 3.13 M | 649.00 K | -8.35 M | 2.80 | CRITICAL | |
 AIM | AIM ImmunoTech Inc. | 0.283 -2.38 % | -35.1% | C 45 | Biotech Clinical | Undervalued | Infectious Disease (viral), On Read More | 3.45 M | 279.48 K | 0.00 | - | -7.30 | 2.15 | 5.88 M | 906.00 K | -9.27 M | 4.60 | DISTRESSED |
 AIMD | Ainos, Inc. | 1.89 -1.05 % | -31.0% | D 37 | Biotech Clinical | Overvalued | 20.12 M | 45.96 K | -0.81 | -462.81 K | -2.90 | 0.96 | 2.84 M | 328.00 K | -9.81 M | 6.70 | CAUTION | |
 AIRS | AirSculpt Technologies, Inc. | 4.33 0.00 % | -21.8% | — | — | — | 368.25 M | 403.16 K | -29.51 | 153.60 K | -0.18 | 0.72 | 16.69 M | 624.92 K | 12.42 M | 26.71 | PROFITABLE | |
A AKAN | Akanda Corp. Common Shares | 9.94 -1.09 % | -54.6% | Pharma | — | 1.26 M | 16.14 K | 0.00 | - | 0.00 | NaN | - | - | - | NaN | — | ||
 AKBA | Akebia Therapeutics, Inc. | 1.4 -2.10 % | +33.3% | B 74 | Pharma Commercial | Undervalued | Hematology/Coagulation, Renal Read More | 251.20 M | 4.15 M | -12.15 | -124.40 K | -0.08 | 7.96 | 162.64 M | 7.07 M | 6.57 M | 20.80 | STABLE |